RT-PCR and in situ hybridization analysis of apolipoprotein H expression in rat normal tissues

International Journal of Molecular Medicine

Volumn 18, Issue 3, 2006, Pages 449-455

  Ragusa, Maria A ^a   Costa, Salvatore ^a   Cefalù, Angelo B ^a   Noto, Davide ^a   Fayer, Francesca ^a   Travali, Salvatore ^b   Averna, Maurizio R ^a   Gianguzza, Fabrizio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antiphospholipid syndrome; apoH; Fanconi syndrome; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; GLYCOPROTEIN; MESSENGER RNA;

ANIMAL; ARTICLE; CELL CULTURE; GENE EXPRESSION PROFILING; HEART MUSCLE; HUMAN; IN SITU HYBRIDIZATION; JEJUNUM; KIDNEY; LIVER; METABOLISM; METHODOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; BETA 2-GLYCOPROTEIN I; CELLS, CULTURED; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; IN SITU HYBRIDIZATION; JEJUNUM; KIDNEY; LIVER; MYOCARDIUM; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 33750594443     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.3.449     Document Type: Article

References (52)

1. Polz E and Kostner GM: The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett 102: 183-186, 1979.
2. Lee NS, Brewer HB Jr and Osborne JC Jr: Beta 2-glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J Biol Chem 258: 4765-4770, 1983.
3. Day AJ, Campbell RD and Reid KBM: The mosaic nature of the complement proteins. In: Progress in Immunology VII. Melchers F, et al (eds). Springer-Verlag, Berlin, Heidelberg, 1989.
4. Hammel M, Schwarzenbacher R, Gries A, Kostner GM, Laggner P and Prassl R: Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes. Biochemistry 40: 14173-14181, 2001.
5. Bouma B, de Groot PG, van den Elsen JM, Ravelli RB, Schouten A, Simmelink MJ, Derksen RH, Kroon J and Gros P: Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J 18: 5166-5174, 1999.
6. Schwarzenbacher R, Zeth K, Diederichs K, Gries A, Kostner GM, Laggner P and Prassl R: Crystal structure of human beta2- glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 18: 6228-6239, 1999. (Pubitemid 29533227)
7. Kroll J, Larsen JK, Loft H, Ezban M, Wallevik K and Faber M: DNA-binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta 434: 490-501, 1976.
8. Polz E: Isolation of a specific lipid binding protein from human serum by affinity chromatography using heparin-sepharose. In Protides of biological fluids. Peeters H (ed). Pergamon Press, Oxford, 1979.
9. Schousboe I: Purification, characterization and identification of an agglutinin in human serum. Biochim Biophys Acta 579: 396-408, 1979. (Pubitemid 9254839)
10. Wurm H: Beta 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 16: 511-515, 1984.
11. McNeil HP, Simpson RJ, Chesterman CN and Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2- glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87: 4120-4124, 1990.
12. Roubey RA, Pratt CW, Buyon JP and Winfield JB: Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J Clin Invest 90: 1100-1104, 1992.
13. Roubey RA: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 84: 2854-2867, 1994.
14. Wang MX, Kandiah DA, Ichikawa K, Khamashta M, Hughes G, Koike T, Roubey R and Krilis SA: Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 155: 1629-1636, 1995.
15. Norden AG, Fulcher LM, Lapsley M and Flynn FV: Excretion of beta 2-glycoprotein I (apolipoprotein H) in renal tubular disease. Clin Chem 37: 74-77, 1991.
16. Schousboe I: Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity. Thromb Res 19: 225-237, 1980.
17. Nimpf J, Wurm H and Kostner GM: Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 63: 109-114, 1987. (Pubitemid 17232740)
18. Nimpf J, Bevers EM, Bomans PH, Till U, Wurm H, Kostner GM and Zwaal RF: Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta 884: 142-149, 1986.
19. Wurm H, Beubler E, Polz E, Holasek A and Kostner G: Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat. Metabolism 31: 484-486, 1982.
20. Schousboe I: Beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66: 1086-1091, 1985.
21. Balasubramanian K, Chandra J and Schroit AJ: Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biol Chem 272: 31113-31117, 1997.
22. Yan X, Morselt HW, Scherphof GL, Poelstra K and Kamps JA: The role of beta2-glycoprotein I in liposome-hepatocyte interaction. Biochim Biophys Acta 1667: 208-214, 2004.
23. Bevers EM, Zwaal RF and Willems GM: The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin. Clin Immunol 112: 150-160, 2004.
24. Kristensen T, Schousboe I, Boel E, Mulvihill EM, Hansen RR, Moller KB, Moller NP and Sottrup-Jensen L: Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA. FEBS Lett 289: 183-186, 1991.
25. Mehdi H, Nunn M, Steel DM, Whitehead AS, Perez M, Walker L and Peeples ME: Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2-glycoprotein I). Gene 108: 293-298, 1991.
26. Steinkasserer A, Estaller C, Weiss EH, Sim RB and Day AJ: Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. Biochem J 277: 387-391, 1991.
27. Aoyama Y, Chan YL and Wool IG: The primary structure of rat beta 2-glycoprotein I. Nucleic Acids Res 17: 6401, 1989.
28. Nonaka M, Matsuda Y, Shiroishi T, Moriwaki K, Nonaka M and Natsuume-Sakai S: Molecular cloning of mouse beta 2- glycoprotein I and mapping of the gene to chromosome 11. Genomics 13: 1082-1087, 1992.
29. Sellar GC, Steel DM, Zafiropoulos A, Seery LT and Whitehead AS: Characterization, expression and evolution of mouse beta 2-glycoprotein I (apolipoprotein H). Biochem Biophys Res Commun 200: 1521-1528, 1994.
30. Sellar GC, Keane J, Mehdi H, Peeples ME, Browne N and Whitehead AS: Characterization and acute phase modulation of canine apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun 191: 1288-1293, 1993.
31. Kato H and Enjyoji K: Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains. Biochemistry 30: 11687-11694, 1991.
32. Bendixen E, Halkier T, Magnusson S, Sottrup-Jensen L and Kristensen T: Complete primary structure of bovine beta 2- glycoprotein I: localization of the disulfide bridges. Biochemistry 31: 3611-3617, 1992.
33. Gao B, Virmani M, Romm E, Lazar-Wesley E, Sakaguchi K, Appella E, Kunos G and Takacs L: Sequence of a cDNA encoding bovine apolipoprotein H. Gene 126: 287-288, 1993. (Pubitemid 223034647)
34. Sanghera DK, Nestlerode CS, Ferrell RE and Kamboh MI: Chimpanzee apolipoprotein H (beta2-glycoprotein I): report on the gene structure, a common polymorphism, and a high prevalence of antiphospholipid antibodies. Hum Genet 109: 63-72, 2001.
35. Averna M, Paravizzini G, Marino G, Lanteri E, Cavera G, Barbagallo CM, Petralia S, Cavallaro S, Magro G, Grasso S, Notarbartolo A and Travali S: Liver is not the unique site of synthesis of beta 2-glycoprotein I (apolipoprotein H): evidence for an intestinal localization. Int J Clin Lab Res 27: 207-212, 1997.
36. Chamley LW, Allen JL and Johnson PM: Synthesis of beta2 glycoprotein 1 by the human placenta. Placenta 18: 403-410, 1997.
37. Day JR, O'Hara PJ, Grant FJ, Lofton-Day C, Berkaw MN, Werner P and Arnaud P: Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (beta 2- glycoprotein I). Int J Clin Lab Res 21: 256-263, 1992.
38. Steinkasserer A, Cockburn DJ, Black DM, Boyd Y, Solomon E and Sim RB: Assignment of apolipoprotein H (APOH: beta-2- glycoprotein I) to human chromosome 17q23-qter; determination of the major expression site. Cytogenet Cell Genet 60: 31-33, 1992.
39. Alvarado-de la Barrera C, Bahena S, Llorente L, Martinez-Castillo A, Alarcon-Segovia D and Cabral AR: Beta2-glycoprotein- I mRNA transcripts are expressed by hepatocytes but not by resting or activated human endothelial cells. Thromb Res 90: 239-243, 1998.
40. Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Palladini G and Valesini G: Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in antiphospholipid syndrome-related tissue damage. Clin Exp Immunol 115: 214-219, 1999. (Pubitemid 29030388)
41. Conti F, Sorice M, Circella A, Alessandri C, Pittoni V, Caronti B, Calderaro C, Griggi T, Misasi R and Valesini G: Beta-2- glycoprotein I expression on monocytes is increased in antiphospholipid antibody syndrome and correlates with tissue factor expression. Clin Exp Immunol 132: 509-516, 2003.
42. Averna M, Paravizzini G, Marino G, Emmanuele G, Cefalu AB, Magro G, Bartoloni G, Ragusa M, Noto D, Barbagallo CM, Callari D, Mazzarino MC, Notarbartolo A and Travali S: Beta- 2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes. Int J Biochem Cell Biol 36: 1297-1305, 2004.
43. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
44. Moorman AF, Houweling AC, de Boer PA and Christoffels VM: Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol. J Histochem Cytochem 49: 1-8, 2001.
45. Sheng Y, Herzog H and Krilis SA: Cloning and characterization of the gene encoding the mouse beta 2-glycoprotein I. Genomics 41: 128-130, 1997.
46. Okkels H, Rasmussen TE, Sanghera DK, Kamboh MI and Kristensen T: Structure of the human beta2-glycoprotein I (apolipoprotein H) gene. Eur J Biochem 259: 435-440, 1999.
47. Christensen EI and Birn H: Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 280: F562-F573, 2001.
48. Klaerke DA, Rojkjaer R, Christensen L and Schousboe I: Identification of beta2-glycoprotein I as a membrane-associated protein in kidney: purification by calmodulin affinity chromatography. Biochim Biophys Acta 1339: 203-216, 1997.
49. Ishida T, Harashima H and Kiwada H: Liposome clearance. Biosci Rep 22: 197-224, 2002.
50. Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G and Meroni PL: Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 13: 179-185, 1995.
51. Le Tonqueze M, Salozhin K, Dueymes M, Piette JC, Kovalev V, Shoenfeld Y, Nassonov E and Youinou P: Role of beta 2- glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus 4: 179-186, 1995.
52. Meroni PL, Raschi E, Testoni C and Borghi MO: Endothelial cell activation by antiphospholipid antibodies. Clin Immunol 112: 169-174, 2004.